J B Marshall, A D Forker. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultAgedAmitriptyline/adverse effectsAmitriptyline/bloodAmitriptyline/therapeutic useAntidepressive Agents, Tricyclic/adverse effectsAntidepressive Agents, Tricyclic/bloodAntidepressive Agents, Tricyclic/therapeutic useArrhythmias, Cardiac/chemically inducedArrhythmias, Cardiac/mortalityCardiovascular System/drug effectsChildDepression/drug therapyDepression/mortalityDepression/physiopathologyDesipramine/adverse effectsDesipramine/bloodDesipramine/therapeutic useDoxepin/adverse effectsDoxepin/bloodDoxepin/therapeutic useElectrocardiographyHemodynamics/drug effectsHumansHypotension/chemically inducedHypotension/mortalityImipramine/adverse effectsImipramine/bloodImipramine/therapeutic useKineticsMiddle AgedMyocardium/metabolismNorepinephrine/metabolismParasympatholytics/pharmacologyProtriptyline/adverse effectsProtriptyline/bloodProtriptyline/therapeutic use
Substances: See more » Antidepressive Agents, TricyclicParasympatholyticsDoxepinAmitriptylineProtriptylineImipramineDesipramineNorepinephrine
Year: 1982 PMID: 7039280 DOI: 10.1016/0002-8703(82)90281-2
Source DB: PubMed Journal: Am Heart J ISSN: 0002-8703 Impact factor: 4.749